
    
      The purpose of the study is to assess the safety and performance of the Optimum TAV
      (Transcatheter Aortic Valve) in patients with symptomatic, severe aortic stenosis who are
      deemed high-risk for SAVR (Surgical Aortic Valve Replacement) or have contraindications or
      deemed inoperable for SAVR.
    
  